These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 37352915)

  • 21. RIPK1 inhibitor ameliorates the MPP
    Liu J; Hu H; Wu B
    Brain Res; 2021 Apr; 1757():147310. PubMed ID: 33524379
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Homer1 knockdown protects dopamine neurons through regulating calcium homeostasis in an in vitro model of Parkinson's disease.
    Chen T; Yang YF; Luo P; Liu W; Dai SH; Zheng XR; Fei Z; Jiang XF
    Cell Signal; 2013 Dec; 25(12):2863-70. PubMed ID: 24036210
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Apelin-36 mitigates MPTP/MPP
    Zhu J; Dou S; Wang C; Jiang Y; Wang C; Cheng B
    Brain Res; 2019 Oct; 1721():146334. PubMed ID: 31306618
    [TBL] [Abstract][Full Text] [Related]  

  • 24. LncRNA BDNF-AS promotes autophagy and apoptosis in MPTP-induced Parkinson's disease via ablating microRNA-125b-5p.
    Fan Y; Zhao X; Lu K; Cheng G
    Brain Res Bull; 2020 Apr; 157():119-127. PubMed ID: 32057951
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Overexpression of TFAM, NRF-1 and myr-AKT protects the MPP(+)-induced mitochondrial dysfunctions in neuronal cells.
    Piao Y; Kim HG; Oh MS; Pak YK
    Biochim Biophys Acta; 2012 May; 1820(5):577-85. PubMed ID: 21856379
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Targeting microglial NLRP3 in the SNc region as a promising disease-modifying therapy for Parkinson's disease.
    Qiao C; Dang T; Zhou Y; Zhou YZ; Zhao R; Wang M
    Brain Behav; 2022 Nov; 12(11):e2784. PubMed ID: 36199191
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The peptidyl-prolyl isomerase Pin1 up-regulation and proapoptotic function in dopaminergic neurons: relevance to the pathogenesis of Parkinson disease.
    Ghosh A; Saminathan H; Kanthasamy A; Anantharam V; Jin H; Sondarva G; Harischandra DS; Qian Z; Rana A; Kanthasamy AG
    J Biol Chem; 2013 Jul; 288(30):21955-71. PubMed ID: 23754278
    [TBL] [Abstract][Full Text] [Related]  

  • 28. TRPC1-mediated inhibition of 1-methyl-4-phenylpyridinium ion neurotoxicity in human SH-SY5Y neuroblastoma cells.
    Bollimuntha S; Singh BB; Shavali S; Sharma SK; Ebadi M
    J Biol Chem; 2005 Jan; 280(3):2132-40. PubMed ID: 15542611
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A Mouse Model of 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine (MPTP)-Induced Parkinson Disease Shows that 2-Aminoquinoline Targets JNK Phosphorylation.
    Zhu M; Gong D
    Med Sci Monit; 2020 Apr; 26():e920989. PubMed ID: 32333598
    [TBL] [Abstract][Full Text] [Related]  

  • 30. TRPC1 as a negative regulator for TRPC4 and TRPC5 channels.
    Kim J; Ko J; Myeong J; Kwak M; Hong C; So I
    Pflugers Arch; 2019 Aug; 471(8):1045-1053. PubMed ID: 31222490
    [TBL] [Abstract][Full Text] [Related]  

  • 31. PEP-1-GLRX1 Reduces Dopaminergic Neuronal Cell Loss by Modulating MAPK and Apoptosis Signaling in Parkinson's Disease.
    Choi YJ; Kim DW; Shin MJ; Yeo HJ; Yeo EJ; Lee LR; Song Y; Kim DS; Han KH; Park J; Lee KW; Park JK; Eum WS; Choi SY
    Molecules; 2021 Jun; 26(11):. PubMed ID: 34206041
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibitors of mitochondrial respiration, iron (II), and hydroxyl radical evoke release and extracellular hydrolysis of glutathione in rat striatum and substantia nigra: potential implications to Parkinson's disease.
    Han J; Cheng FC; Yang Z; Dryhurst G
    J Neurochem; 1999 Oct; 73(4):1683-95. PubMed ID: 10501216
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nimodipine, an L-type calcium channel blocker attenuates mitochondrial dysfunctions to protect against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinsonism in mice.
    Singh A; Verma P; Balaji G; Samantaray S; Mohanakumar KP
    Neurochem Int; 2016 Oct; 99():221-232. PubMed ID: 27395789
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Secalonic acid A protects dopaminergic neurons from 1-methyl-4-phenylpyridinium (MPP⁺)-induced cell death via the mitochondrial apoptotic pathway.
    Zhai A; Zhu X; Wang X; Chen R; Wang H
    Eur J Pharmacol; 2013 Aug; 713(1-3):58-67. PubMed ID: 23665112
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reduced dopaminergic neuron degeneration and global transcriptional changes in Parkinson's disease mouse brains engrafted with human neural stems during the early disease stage.
    Pereira MCL; Boese AC; Murad R; Yin J; Hamblin MH; Lee JP
    Exp Neurol; 2022 Jun; 352():114042. PubMed ID: 35271839
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neuroprotective effect of hyperoside in MPP
    Xu XJ; Pan T; Fan HJ; Wang X; Yu JZ; Zhang HF; Xiao BG; Li ZY; Zhang B; Ma CG; Chai Z
    Metab Brain Dis; 2023 Mar; 38(3):1035-1050. PubMed ID: 36576692
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Alpha-Lipoic Acid Attenuates MPTP/MPP
    Zhang J; Gao Y; Zhang L; Zhang C; Zhao Y; Zhang Y; Li S; Chang C; Zhang X; Yang G
    Neurotox Res; 2022 Apr; 40(2):410-419. PubMed ID: 35146598
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neuroprotective effects of TRPV1 by targeting GDF11 in the Mpp+/MPTP-induced Parkinson's disease model.
    Zhang K; Liu P; Yuan L; Geng Z; Li B; Zhang B
    Biochem Biophys Res Commun; 2022 Oct; 623():104-110. PubMed ID: 35921703
    [TBL] [Abstract][Full Text] [Related]  

  • 39. SNHG1 promotes MPP
    Zhao J; Geng L; Chen Y; Wu C
    Biol Res; 2020 Jan; 53(1):1. PubMed ID: 31907031
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of the TLR/NF-
    Su Y; Li M; Wang Q; Xu X; Qin P; Huang H; Zhang Y; Zhou Y; Yan J
    Oxid Med Cell Longev; 2022; 2022():1837278. PubMed ID: 36589679
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.